November 6, 2021, 7 p.m. (ChST)
COVID-19 Updates: Preliminary Test Results: 38 New Cases, 43 Hospitalized;
Monoclonal Antibody Therapy Treatment Continues;
Food Commodities Distribution Continues
43 Hospitalized for COVID-19
SPECIAL NOTE: Based on today's data, if we were to compare two (2) hypothetical populations of 100,000 people each, vaccinated versus unvaccinated, there would be 19 vaccinated people hospitalized for COVID-19 compared to 140 unvaccinated people hospitalized for COVID- 19. The risk of being hospitalized for COVID-19 is about 7 times higher for the unvaccinated as compared to the vaccinated.
*Population is based on the 2018 Statistical Yearbook.
Preliminary COVID-19 Test Results: 38 New Cases
Today, the Department of Public Health and Social Services (DPHSS) reported a preliminary case count of 38 new cases of COVID-19 from 509 specimens analyzed on November 5. Additional results are pending analysis and submission from other clinics and will be reported on Monday, November 8. To date, there have been a total of 18,624 officially reported cases, 248 deaths, 2,595 cases in active isolation, and 15,781 not in active isolation. As of November 5, the CAR Score is 9.0.
Community Reminded to Continue Wearing Face Masks
As established by prior executive order and upheld under Section 3 of Executive Order 2021-27, individuals are reminded that they are required to wear face masks when returning off-base from military installations. Wearing of face masks is required in congregate settings, whether indoors or outdoors, in accordance with DPHSS Guidance, regardless of vaccination status.
Monoclonal Antibody Therapy Treatment Continues
DPHSS, in partnership with the Mayors’ Council of Guam and the Guam National Guard, continues to offer outpatient monoclonal antibody (mAb) therapy at the Mangilao Senior Citizens Center in Mangilao. Patients who have tested positive for COVID-19 may receive mAb therapy if they meet the eligibility criteria through a referral from their private physician, a COVID-19 community test site, or a hospital. A Pre-Screening Assessment has been developed to guide individuals who may be eligible for mAb treatment. To schedule an appointment, call 671-998-4627 from 8 a.m. to 4 p.m. or 671-734-9203 from 4 p.m. to 8 p.m. Monday through Saturday. For more information, CLICK HERE.
For individuals who received a Pfizer-BioNTech or Moderna COVID-19 vaccine (first two doses), the following groups are eligible for a booster shot at 6 months or more after their initial series:
Anyone age 65 years and older
Anyone age 18 years and older with underlying medical conditions
Anyone 18 years and older with an elevated risk of CO